In clinical practice, patients or family members of liver cancer often ask me if they can combine Chinese medicine with interventional treatment, which I do not advocate. In the Chinese tradition, there is a deep affection for TCM, and the evidence-based treatment of TCM is also deeply rooted in people’s hearts, and there are often miracles of TCM doctors bringing back to life in the media or by word of mouth. Therefore, Chinese people believe that combined treatment of Chinese and Western medicine is better than Western medicine. However, for liver cancer patients, I do not advocate taking Chinese medicine. Chinese medicine generally considers tumor as “knot”, “stasis” and “poison”, and often adopts “softening and dispersing knots” and “invigorating blood circulation and removing toxins” to treat tumor. In treating tumors, they often use “softening and dispersing knots”, “activating blood circulation and removing blood stasis”, “attacking poison with poison” and “clearing heat and detoxifying”. Although liver cancer has the general characteristics of tumor, its growth, metastasis and recurrence are closely related to angiogenesis. In the interventional treatment, why can the tumor be well controlled by just iodinated oil and emulsion made of chemotherapy drugs, which is embolized into the blood vessels of liver cancer, and why can it be the preferred treatment method besides surgical resection? How can Sorafenib (Doxorubicin) become the only molecularly targeted drug that can effectively treat patients with intermediate to advanced hepatocellular carcinoma in the world today? It has become the first-line drug for the treatment of advanced hepatocellular carcinoma in Europe and America. It is because, one of the important functions of Doxorubicin – inhibiting angiogenesis. It can be seen that the treatment of liver cancer needs to embolize and inhibit the blood vessels of the tumor, while the concept of activating blood stasis and softening hard nodes in Chinese medicine is just the opposite. Liver cancer in Chinese is closely related to post-hepatitis cirrhosis, and most patients with liver cancer have a background of cirrhosis and inadequate liver reserve function. And anything we eat has to be metabolized and detoxified in the liver. The formula of “attacking poison with poison and detoxifying heat” often aggravates the burden of liver and liver function, and it is harmful to take it while interventional treatment. Therefore, I do not advocate patients with liver cancer to take Chinese medicine, but if I meet a patient who insists on taking Chinese medicine, I will advise him/her to take a formula that is “warming, harmonizing the stomach and regulating qi”.